SPOTLIGHT -
ASRS 2019 Street Team: Rishi P. Singh, MD
ASRS
ICYMI: Dr. Singh shares the take-home message from his 2019 presentation
ASRS 2019 Street Team: Charles C. Wykoff, MD, PhD
ICMYI: Dr. Wykoff discusses results from his ASRS presentation
ASRS 2019 Street Team: Raj K. Maturi, MD
ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process
US, international physicians mostly in agreement over treatment practices
This year’s ASRS PAT survey show subtle regional differences
Global trends show similar patterns worldwide
The ASRS Global Trends Survey finds differences in some treatment preferences
ASRS 2019 Street Team: John T. Thompson, MD
ICYMI: ASRS-developed program aims to support physicians with confidential comparisons
ASRS 2019 Street Team: Josh Mali, MD
Ever wondered what it's like to compete in a Shark Tank-like competition? Find out!
Migraines and retinal perfusion: A headache for physicians, patients
Optical coherence tomography angiography can detect microcirculatory disturbances during acute attacks.
ASRS 2019 Street Team: Netan Choudhry, MD, FRCSC, DABO
Defining medicine and terms used can help move science forward
ASRS 2019 Street Team: Justis P. Ehlers, MD
Researchers seeking fluid features, retinal integrity measures to test next step in image analysis and image interrogation in clinical trials.
ASRS 2019 Street Team: David S. Boyer, MD
David S. Boyer, MD, notes that the goal is to dry every patient out, with undertreatment the leading cause of a loss of visual acuity.
Intraoperative surgical methods hold key to AMD treatment
Researchers find that targeted subretinal delivery of stem cell derived RPE to geographic atrophy is feasible
Novel treatments in pipeline for diabetic eye disease
AAO
Patrik De Haes, MD, CEO of Oxurion NV, shares the latest updates in clinical studies at the OIS@AAO meeting in Chicago, Oct. 2018.
Intestinal microbiome proposed as potential therapeutic target for AMD
Nanotechnology strategies explored as novel therapeutic approach to photoreceptor blindness
Refillable implant releasing ranibizumab in phase III study
Schepens Lecturer shares ideas for moving forward in AMD
Three pearls for uveitis diagnosis
Success in retinal detachment surgery depends on using the right strategies
Understanding the variances of hypersonic vitrector settings
Sunir J. Garg, MD, discusses hypersonic vitrector settings in surgery in the exhibition hall at ASRS 2018 in Vancouver.
Risuteganib for the treatment of DME
CEO of Aerie Pharmaceuticals provides a brief company overview at OIS meeting
Global trends in retina: How surgeons are practicing in 2018
Oral therapy may be viable for CSC
Fellows report increasing surgical experience during training
Why microscope-integrated OCT is vital to gene therapy
Numerous advances in diabetic eye disease, but many questions remain
What makes pneumatic vitreolysis 'highly effective' for VMT
What APL-2 means for geographic atrophy
How AMD patients are treated in the 'real world'